Using murine models of graft-versus-host disease (GVHD), researchers showed that STAT3–/– donor T cells induced only mild reversible acute GVHD while preserving graft-versus-leukemia effects against nonsusceptible acute lymphoblastic leukemia cells in a donor T cell dose–dependent manner.
[Journal Of Clinical Investigation]